Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently issued new draft guidance to industry for developing plans to enroll more participants from underrepresented racial and ethnic populations in …
FDA Takes Steps to Increase Racial and Ethnic Diversity in Clinical Trials Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) this week announced that corrected results from its Phase 3 ROMAN trial of avasopasem for the treatment of RT-induced severe oral mucositis …
Galera Announces Primary Endpoint Met Statistical Significance in Corrected Topline Efficacy Data of Phase 3 ROMAN Trial of Avasopasem Read More
WASHINGTON, D.C. — The following quote is attributed to Acting FDA Commissioner Janet Woodcock, M.D.:
FDA Takes New Steps Aimed at Advancing Development of Individualized Medicines to Treat Genetic Diseases Read More
RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) announced this week that it has completed an analysis to identify clinical evidence that indicates a substantial improvement after treatment with ZYESAMI® (aviptadil) …
NRx Pharmaceuticals Identifies Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19 in ZYESAMI Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced positive preliminary topline results from its first in …
Aclaris Therapeutics Announces Positive Preliminary Topline Data from Phase 2a Trial of ATI-1777 Read More